Skip to main content
Clinical Trials/NCT06098183
NCT06098183
Completed
Not Applicable

Metabolic Effects of Muscle and Exercise Across Perimenopause

University of North Carolina, Chapel Hill1 site in 1 country28 target enrollmentMarch 22, 2024

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Perimenopausal Disorder
Sponsor
University of North Carolina, Chapel Hill
Enrollment
28
Locations
1
Primary Endpoint
Change in energy expenditure (kcals/day) from baseline and 30 minutes post-exercise.
Status
Completed
Last Updated
7 months ago

Overview

Brief Summary

Starting in early-perimenopause, changes in systemic and tissue level metabolism result in an accelerated loss of muscle mass and an increase in body fat. Our preliminary work indicates that metabolic alterations, specifically a decrease in whole-body protein balance, increase in abdominal adiposity, and reduced metabolic flexibility during exercise is most evident in perimenopause. Exercise is a potent stimulator of skeletal muscle insulin sensitivity. High intensity interval training (HIIT) has been shown to be an effective exercise strategy to support cardiometabolic health in overweight and obese young women. Skeletal muscle is critical to maintaining metabolic health and functionality across the lifespan, and is considered the primary diver of whole-body insulin resistance.There is a significant decrease in muscle mass across the menopause transition, which is often exacerbated by a significant gain in fat mass and visceral fat. Protein consumption prior to HIIT has resulted in improvements in energy expenditure and fat oxidation in young women. The overarching objective of this study is to determine the metabolic response of HIIT compared to traditional aerobic exercise in early and late perimenopausal women. Aim 1 will examine the metabolic responses (glucose, insulin sensitivity, energy expenditure) of HIIT vs aerobic exercise, combined with pre-exercise carbohydrate or protein ingestion, in overweight/obese (BMI: 28-40 Kg/m^2) early and late perimenopausal women. Aim 2 will explore the impact of perimenopause on the fat oxidation and protein turnover before and after exercise. Lastly, aim 3 will explore the modulating effect of intramuscular fat on these metabolic outcomes.

Registry
clinicaltrials.gov
Start Date
March 22, 2024
End Date
August 8, 2025
Last Updated
7 months ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Early and late perimenopausal women (≥38 years; early: experienced menstrual bleeding in the previous 3 months with a decrease in cycle regularity in the past year; late: no menstrual bleeding in the previous 3 months with some bleeding in the previous year).
  • Overweight and obese: body mass index (BMI) of 28 - 40 Kg/m\^2 and percent body fat (%BF) ≥ 30%.
  • Healthy, non-smokers.

Exclusion Criteria

  • Have current and/or history of cardiovascular disease, diabetes, metabolic, thyroid, pulmonary, renal, hepatic, gastrointestinal, musculoskeletal disorders or medical or surgical events, such as bariatric surgery, heart surgery, or any joint or musculoskeletal injuries or surgeries occurring in the 6-months prior to enrollment, that may significantly influence study outcomes or prevent safe participation.
  • Gained or lost \>5 kg in the previous 2 months
  • Have a self-identified or clinically diagnosed eating disorder
  • Undergone a full or partial hysterectomy for treatment of menopausal symptoms
  • Have uncontrolled hypertension or an abnormal electrocardiogram.
  • Have an ongoing diagnosed mental disorder with a change in medication in the previous 6 months.
  • Taking metabolism-altering drugs or medications outside of estrogen replacement therapy that may influence study outcomes (i.e. corticosteroids, stimulants, insulin, thyroid medications) or phytoestrogens.
  • Diagnosed with polycystic ovarian syndrome (PCOS).
  • Participating in more than 75 minutes per week of moderate exercise per week.
  • Currently pregnant or planning to become pregnant (determined from urine pregnancy test)

Outcomes

Primary Outcomes

Change in energy expenditure (kcals/day) from baseline and 30 minutes post-exercise.

Time Frame: Baseline and 30 minutes

Indirect calorimetry will be used to obtain energy expenditure prior to exercise and 30 minutes after a bout of high intensity interval training.

Change in respiratory exchange ratio (au) from baseline and up to 60 minutes post-exercise.

Time Frame: Baseline and 60 minutes

Indirect calorimetry will be used to obtain respiratory exchange ratio prior to exercise and 60 minutes after a bout of high intensity interval training.

Change in energy expenditure (kcals/day) from baseline and up to 60 minutes post-exercise.

Time Frame: Baseline and 60 minutes

Indirect calorimetry will be used to obtain energy expenditure prior to exercise and 60 minutes after a bout of high intensity interval training.

Change in respiratory exchange ratio (au) from baseline and 30 minutes post-exercise.

Time Frame: Baseline and 30 minutes

Indirect calorimetry will be used to obtain respiratory exchange ratio prior to exercise 30 minutes after a bout of high intensity interval training.

Secondary Outcomes

  • Area under the curve for fat oxidation(Baseline through 60 minutes)
  • Metabolic flexibility(Baseline)
  • Muscle quality(Baseline)
  • Daily Record of Severity of Problems form(Baseline)

Study Sites (1)

Loading locations...

Similar Trials